You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Tested Applications | WB |
|---|---|
| Application Notes |
Key Properties
−| Source | HEK293 cells |
|---|---|
| Target | CX3CL1 |
| Tag | His Tag |
| MW | 35.5 kDa |
| Purity | >95% as determined by SDS-PAGE.Endotoxin level is less than 1.0 EU per ug by the LAL method. |
| Protein Sequence | Gln 25 - Gln 341 |
Storage & Handling
−| Storage | Lyophilized Protein should be stored at -20°C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20°C or -70°C. Avoid repeated freeze-thaw cycles. |
|---|---|
| Form/Appearance | Lyophilized |
| Buffer/Preservatives | PBS, pH 7.4 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Recombinant Mouse CX3CL1 Protein [orb2994539]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.3 KDa. Observed: 50-65 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μgRecombinant Human CX3CL1 Protein [orb2995064]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.36 KDa. Observed: 50-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgHuman CX3CL1 Protein, His Tag [orb1826766]
Unconjugated
The purity of the protein is greater than 85% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 34.4 kDa after removal of the signal peptide.
Mammalian
100 μg, 10 μg, 50 μgRecombinant Human CX3CL1/Fractalkine Protein, N-His [orb2961474]
ELISA, SDS-PAGE, WB
>90% as determined by SDS-PAGE.
18.12 kDa
1 mg, 50 μg, 100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].






